紫翔生物 (833866.OC)

+ 收藏

利润表(紫翔生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 56,255,972.55146,943,292.0572,809,005.24143,254,402.3459,976,464.18
 营业收入(元) 56,255,972.55146,943,292.0572,809,005.24143,254,402.3459,976,464.18
二、营业总成本(元) 54,285,580.82132,448,371.8463,730,253.03129,479,303.4856,256,821.61
 营业成本(元) 41,390,557.37108,447,765.2045,642,622.83108,406,015.7538,086,138.04
 营业税金及附加(元) 272,257.49711,542.00378,303.08784,463.38343,382.37
 销售费用(元) 6,933,097.9310,130,073.1911,226,703.118,517,616.2912,700,270.59
 管理费用(元) 5,536,517.2112,669,255.566,008,356.7010,950,244.524,902,314.77
 财务费用(元) 153,150.82489,735.89474,267.31820,963.54224,715.84
  其中:利息费用(元) 142,254.69426,344.89284,048.32464,411.87163,800.04
  其中:利息收入(元) 27,635.7347,885.4826,851.9519,883.4011,048.38
三、其他经营收益
 加:公允价值变动收益(元) -127,859.303,495.4760,135.60-194,574.00130,116.60
 加:投资收益(元) -95,419.65-374,767.76-841,483.81-425,240.41-165,738.95
  其中:对联营企业和合营企业的投资收益(元) -100,211.13-357,675.72-176,822.17-425,240.41-165,738.95
 资产处置收益(元) --17,273.81--22,206.88
 资产减值损失(元) ----22,786.582,485.00
 信用减值损失(元) -529,134.58-217,018.80-101,657.42-801,619.69-275,386.06
 其他收益(元) 13,491.04104,477.8552,987.96181,678.5664,925.75
四、营业利润(元) 1,231,469.2414,011,106.978,266,008.3512,512,556.743,453,838.03
 加:营业外收入(元) 5,349.7747,813.20-19,030.4614,295.29
 减:营业外支出(元) 509.4356,690.096,779.67902,448.82659,103.83
五、利润总额(元) 1,236,309.5814,002,230.088,259,228.6811,629,138.382,809,029.49
 减:所得税费用(元) 909,677.002,418,214.03659,855.31917,678.61231,773.31
六、净利润(元) 326,632.5811,584,016.057,599,373.3710,711,459.772,577,256.18
(一)按经营持续性分类
  持续经营净利润(元) 326,632.5811,584,016.057,599,373.3710,711,459.772,577,256.18
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 645,209.8312,134,552.187,874,659.6310,566,063.482,579,100.16
  少数股东损益(元) -318,577.25-550,536.13-275,286.26145,396.29-1,843.98
 扣除非经常性损益后的净利润(元) 792,234.9112,120,529.358,285,843.1011,383,854.743,173,405.80
七、每股收益
 一、基本每股收益(元) 0.040.770.500.670.16
 二、稀释每股收益(元) 0.040.770.500.670.16
八、其他综合收益(元) ----81.04-1.10
 归属于母公司股东的其他综合收益(元) ----81.04-1.10
九、综合收益总额(元) 326,632.5811,584,016.057,599,373.3710,711,378.732,577,255.08
 归属于母公司所有者的综合收益总额(元) 645,209.8312,134,552.187,874,659.6310,565,982.442,579,099.06
 归属于少数股东的综合收益总额(元) -318,577.25-550,536.13-275,286.26145,396.29-1,843.98
公告日期 2024-08-222024-04-262023-08-232023-03-072022-08-25
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院